Covered recipient · General Payments record
MONICA APRIL USI CO
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$846.31
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $692.59 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $290.45 | 11 |
| PFIZER INC. | $114.05 | 5 |
| Neurocrine BioSciences, Inc. | $108.13 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $40.91 | 2 |
| UCB, Inc. | $37.38 | 2 |
| Alexion Pharmaceuticals, Inc. | $35.57 | 2 |
| Teva Pharmaceuticals USA, Inc. | $25.94 | 1 |
| EISAI INC. | $20.46 | 1 |
| Genentech USA, Inc. | $19.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $34.91 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106929545 | CMS |
| ABBVIE INC. | $14.09 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106929547 | CMS |
| ABBVIE INC. | $28.83 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106929549 | CMS |
| ABBVIE INC. | $23.17 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106929551 | CMS |
| ABBVIE INC. | $35.59 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106929553 | CMS |
| ABBVIE INC. | $17.15 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106929555 | CMS |
| ABBVIE INC. | $21.98 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106929557 | CMS |
| ABBVIE INC. | $28.75 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106929559 | CMS |
| ABBVIE INC. | $29.97 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106929561 | CMS |
| ABBVIE INC. | $29.97 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106929563 | CMS |
| ABBVIE INC. | $26.04 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106929565 | CMS |
| Alexion Pharmaceuticals, Inc. | $18.86 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093967267 | CMS |
| Alexion Pharmaceuticals, Inc. | $16.71 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093883469 | CMS |
| Eisai Inc. | $20.46 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110816194 | CMS |
| Genentech USA, Inc. | $19.70 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133177906 | CMS |
| Neurocrine Biosciences, Inc. | $36.68 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150930569 | CMS |
| Neurocrine Biosciences, Inc. | $37.06 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150930279 | CMS |
| Neurocrine Biosciences, Inc. | $34.39 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150932676 | CMS |
| PFIZER INC. | $20.49 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131575039 | CMS |
| PFIZER INC. | $14.66 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131543208 | CMS |
| PFIZER INC. | $23.32 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131625360 | CMS |
| PFIZER INC. | $27.28 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131657635 | CMS |
| PFIZER INC. | $28.30 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131583938 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.21 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137727022 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.70 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137727024 | CMS |
| Teva Pharmaceuticals USA, Inc. | $25.94 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151542285 | CMS |
| UCB, Inc. | $14.41 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143198521 | CMS |
| UCB, Inc. | $22.97 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143198526 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.